November 13, 2025
The smart healthcare market is expected to rise from USD 397.98 billion in 2026 to USD 1833.7 billion by 2035,...
Read MoreNovember 26, 2025
The U.S. behavioral health market is anticipated to grow from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreNovember 01, 2025
The U.S. digital health market size is forecast to increase from USD 98.69 billion in 2026 to USD 238.65 billi...
Read MoreNovember 13, 2025
The blood pressure measuring devices market is expected to see growth from USD 2.08 billion in 2026 to USD 4.5...
Read MoreNovember 01, 2025
According to market projections, the global direct oral anticoagulants (DOACs) market is projected to reach US$ 102.36 billion by 2034, growing at a CAGR of 8%. Growth is driven by rising cardiovascular cases, preference for oral Factor Xa inhibitors, and expanding R&D in safer, AI-powered treatments....
November 01, 2025
According to market research studies, the global oral Factor Xa inhibitors market was valued at USD 21.5B in 2023 and is projected to reach USD 41.24B by 2034, growing at a CAGR of 6.1%, driven by rising cardiovascular cases, ease of use, and increasing adoption of drugs like apixaban and rivaroxaban....
November 01, 2025
According to market estimations, the global thrombopoietin receptor agonists industry, valued at US$ 1.85 billion in 2023, is set to reach US$ 3.74 billion by 2034, driven by rising platelet-related disorders like ITP and AML. Key trends include FDA approvals, growing R&D, and increasing use in hospitals. North America leads, while Asia-Pacif...
November 01, 2025
North America dominated the human blood products market, fueled by regular donation drives, widespread facilities and government efforts to improve blood storage and awareness. In the U.S., 6.8 million people donate annually, while 52% of Canadians have needed blood or blood products....
November 01, 2025
According to market forecast, the global oral thrombopoietin receptor agonists market is projected to reach US$ 9.95 billion by 2034, driven by rising cases of thrombocytopenia and advancements in TPO-RAs. North America leads, while Asia-Pacific shows strong growth potential. Key players include Novartis, Sobi, and Shionogi....
November 01, 2025
Eltrombopag Drugs Market: In October 2024, Jiaheng (Zhuhai Hengqin) Pharmaceutical Technology Company Limited gained approval from China's National Medical Products Administration to market Eltrombopag Olamine tablets. Additionally, in November 2023, the U.S. FDA authorized Teva's Alvaiz (eltrombopag) tablets for treating thrombocytopenia in adults...
November 01, 2025
Polymerase chain reaction (PCR) is a DNA amplification method widely used in diagnostics and biotechnology. In 2022, India conducted 600-700 million diagnostic tests, adding 1,390 biotech startups. PCR enzymes drive efficiency and sustainability. The U.S. and UK continue to invest heavily in biotech innovation....
November 01, 2025
The nerve repair and regeneration market grows with rising nerve injuries from accidents, chronic disorders, and trauma. Companies like Progentos and Neuraptive advance treatments, with Axogen reporting growth in surgical solutions for peripheral nerve repair. Innovation drives this expanding field....
November 01, 2025
The global human coagulation factor VII market is projected to grow from USD 1.21 billion in 2023 to USD 1.82 billion by 2034, driven by rising surgeries, trauma cases, and hemophilia prevalence. North America leads, while Asia Pacific is the fastest-growing region....
November 01, 2025
The Hepatitis A vaccine market, valued at US$ 759.01 million in 2024, is projected to reach US$ 948.16 million by 2034. Growth is driven by rising outbreaks, immunization awareness, and travel. Asia-Pacific leads, with North America growing fastest; key players include GSK, Merck, and Sanofi....
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com